Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03556449
Other study ID # USSA
Secondary ID 35321-10-72-152-
Status Completed
Phase
First received
Last updated
Start date April 12, 2018
Est. completion date January 31, 2019

Study information

Verified date June 2018
Source Aarhus University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Scapula alata, caused by disturbance in the scapulothoracic stabilizer muscles due to nerve injury, is a relatively rare but also underreported disease. It can lead to years of invalidity of the affected upper extremity, considerable pain and social and emotional consequences for the patients. Unrecognized and misdiagnosed scapula alata and, consequently, wrong or delayed treatment is a general problem in this patient group. Today the diagnosis is based on the clinical examination and the electrophysiological examination. One of the problems is that the electrophysiological examination in a fair part of the patients is not showing any pathology even though the history of the patient and the clinical evaluation are indicating scapula alata. This study is a single-blinded, prospective, controlled multicentre study. The aim of the study is to investigate whether ultrasound can be used as a supplement to the electrophysiological examination when diagnosing scapula alata. Ultrasound will be used to visualize possible thickening of the cross-sectional area of nerves and the degree and pattern of muscle involvement in patients with scapula alata. By comparing measurements from scapula alata patients with the measurements from healthy controls, we are able to see if ultrasound can distinguish these two groups from each other. Furthermore, we will examine whether the ultrasound measurements correlate with the electrophysiological findings in patients and, when available, compare the ultrasound measurements of muscle thickness with MRI (magnetic resonance Imaging) findings. The use of ultrasound in scapula alata patients may help determine the presence and severity of a nerve lesion and the subsequent degree of muscle involvement and may therefore serve as a supplement to the clinical diagnosis.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date January 31, 2019
Est. primary completion date January 31, 2019
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Patients: Inclusion Criteria: - Clinical suspicion of scapula alata Exclusion Criteria: - Winged scapula due to other cause than nerve damage. eg. myopathy Healthy subjects Exclusion Criteria: - History of Shoulder trauma or shoulder disease - History of cervical radiculopathy - History of upper extremity peripheral neuropathy/plexopathy - Peripheral vascular disease

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
High resolution ultrasound
Using a high-frequency linear array transducer (18L6 HD)

Locations

Country Name City State
Denmark Clinic of Neurophysiology, the department of Neurology, Aarhus University Hospital Aarhus

Sponsors (1)

Lead Sponsor Collaborator
Sándor Beniczky

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Thickness of musculus serratus anterior 10-15 minuttes
Primary Thickness of musculus trapezius 10-15 minuttes
Primary Thickness of musculus rhomboideus 10-15 minuttes
Primary Cross sectional area of nervus thoracicus longus 10-15 minuttes
Primary Cross sectional area of nervus accesorius 10-15 minuttes
Primary Cross sectional area of nervus dorsalis scapularis 10-15 minuttes